Vimentin Antikörper (AA 435-466)
Kurzübersicht für Vimentin Antikörper (AA 435-466) (ABIN2745278)
Target
Alle Vimentin (VIM) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 435-466
-
Spezifität
- Highly expressed in fibroblasts, some expression in T- and B-lymphocytes, and little or no expression in Burkitt's lymphoma cell lines. Expressed in many hormone- independent mammary carcinoma cell lines. .
-
Aufreinigung
- Immunogen affinity purified
-
Immunogen
- A synthetic peptide corresponding to a sequence at the C-terminus of human Vimentin (435-466aa DTHSKRTLLIKTVETRDGQVINETSQHHDDLE), identical to the related mouse and rat sequences.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from 5 mg BSA, 0.9 mg sodium chloride, 0.2 mg sodium phosphate, 0.05 mg sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- avoid freeze thaw cycles
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- At -20°C for 1 year. After reconstitution, at 4°C for 1 month. It can also be aliquotted and stored frozen at -20°C for a longer time.Avoid freeze-thaw cycles.
-
-
- Vimentin (VIM)
-
Andere Bezeichnung
- Vimentin
-
Hintergrund
-
Name/Gene ID: VIM
Synonyms: VIM, Vimentin -
Gen-ID
- 7431
-
Pathways
- Caspase Kaskade in der Apoptose
Target
-